IE56366B1 - Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin - Google Patents

Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Info

Publication number
IE56366B1
IE56366B1 IE2896/83A IE289683A IE56366B1 IE 56366 B1 IE56366 B1 IE 56366B1 IE 2896/83 A IE2896/83 A IE 2896/83A IE 289683 A IE289683 A IE 289683A IE 56366 B1 IE56366 B1 IE 56366B1
Authority
IE
Ireland
Prior art keywords
component
composition according
molecular weight
pharmaceutically acceptable
composition
Prior art date
Application number
IE2896/83A
Other languages
English (en)
Other versions
IE832896L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE832896L publication Critical patent/IE832896L/xx
Publication of IE56366B1 publication Critical patent/IE56366B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE2896/83A 1982-12-10 1983-12-09 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin IE56366B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (2)

Publication Number Publication Date
IE832896L IE832896L (en) 1984-06-10
IE56366B1 true IE56366B1 (en) 1991-07-03

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2896/83A IE56366B1 (en) 1982-12-10 1983-12-09 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (OSRAM)
AT (1) AT382514B (OSRAM)
AU (1) AU570658B2 (OSRAM)
BE (1) BE898356A (OSRAM)
CA (1) CA1224416A (OSRAM)
CH (1) CH656533A5 (OSRAM)
CY (1) CY1509A (OSRAM)
DD (1) DD215469B3 (OSRAM)
DK (1) DK162475C (OSRAM)
FR (1) FR2537435B1 (OSRAM)
GB (1) GB2131691B (OSRAM)
GR (1) GR79745B (OSRAM)
HK (1) HK23290A (OSRAM)
HU (1) HU190513B (OSRAM)
IE (1) IE56366B1 (OSRAM)
IL (1) IL70406A (OSRAM)
IT (1) IT1172368B (OSRAM)
LU (1) LU85127A1 (OSRAM)
NL (1) NL8304221A (OSRAM)
NZ (1) NZ206523A (OSRAM)
PH (1) PH23451A (OSRAM)
PT (1) PT77803B (OSRAM)
SE (1) SE468973B (OSRAM)
SG (1) SG53989G (OSRAM)
ZA (1) ZA839200B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
GR79745B (OSRAM) 1984-10-31
IT8349456A0 (it) 1983-12-07
SG53989G (en) 1989-12-29
JPS59116222A (ja) 1984-07-05
DK162475C (da) 1992-05-11
GB2131691B (en) 1986-12-03
SE468973B (sv) 1993-04-26
NL8304221A (nl) 1984-07-02
DK162475B (da) 1991-11-04
NZ206523A (en) 1987-04-30
PH23451A (en) 1989-08-07
IT8349456A1 (it) 1985-06-07
BE898356A (fr) 1984-06-04
FR2537435A1 (fr) 1984-06-15
DK565783D0 (da) 1983-12-08
CH656533A5 (de) 1986-07-15
FR2537435B1 (fr) 1987-03-20
HK23290A (en) 1990-04-06
PT77803A (en) 1984-01-01
CY1509A (en) 1990-08-03
IT1172368B (it) 1987-06-18
DK565783A (da) 1984-06-11
IL70406A0 (en) 1984-03-30
DD215469B3 (de) 1988-03-09
DD215469A5 (de) 1984-11-14
SE8306792D0 (sv) 1983-12-08
HUT34124A (en) 1985-02-28
IE832896L (en) 1984-06-10
GB8332653D0 (en) 1984-01-11
JPH0672101B2 (ja) 1994-09-14
ZA839200B (en) 1985-07-31
IL70406A (en) 1988-08-31
LU85127A1 (fr) 1984-10-22
PT77803B (en) 1986-04-17
SE8306792L (sv) 1984-06-11
AU570658B2 (en) 1988-03-24
HU190513B (en) 1986-09-29
GB2131691A (en) 1984-06-27
AT382514B (de) 1987-03-10
CA1224416A (en) 1987-07-21
ATA428483A (de) 1986-08-15
AU2222183A (en) 1984-06-14

Similar Documents

Publication Publication Date Title
CA2268967C (en) Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
RU2068260C1 (ru) Глазные капли
JP2003505419A (ja) ケトチフェンを含む眼用組成物
EP0233615B1 (en) Aqueous preparation and method of preparation thereof
US20220378803A1 (en) Injectable compositions of ursodeoxycholic acid
IE56366B1 (en) Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin
KR100342367B1 (ko) 녹내장치료제및안압강하제
EP0277462A1 (de) Verfahren zur Herstellung nasaler Lösungen enthaltend synthetisches Human calcitonin.
US5955456A (en) Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
US5561154A (en) Treatment of acute urinary retention
RU2218156C2 (ru) Способ изготовления состава местных бета-блокаторов улучшенного действия
CN114364401A (zh) 防止含有对二羟硼基苯丙氨酸的注射液剂的析出的方法
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
EP1508332A1 (en) Medicinal composition
IE50372B1 (en) Stable solutions of hydrogenated egotalkaloids
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
HK40063208A (en) Method for preventing precipitation of injectable solution containing p-boronophenylalanine
DE3701461C2 (OSRAM)
KR19990023971A (ko) 크로만 유도체를 함유하는 안과용 용제
DE2312060A1 (de) Mittel zur hemmung der blutplaettchenaggregation
DE3608684A1 (de) Neues therapeutisches praeparat enthaltend hydrierte ergotalkaloide und ein gegen aktivitaetsverlust stabilisiertes niedermolekulares heparin
HK1023518B (en) Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
MXPA99003616A (en) Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
DE3343818A1 (de) Neues therapeutisches praeparat enthaltend hydrierte ergotalkaloide und heparin

Legal Events

Date Code Title Description
MM4A Patent lapsed